These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


262 related items for PubMed ID: 15612859

  • 1. Cue-provoked craving and nicotine replacement therapy in smoking cessation.
    Waters AJ, Shiffman S, Sayette MA, Paty JA, Gwaltney CJ, Balabanis MH.
    J Consult Clin Psychol; 2004 Dec; 72(6):1136-43. PubMed ID: 15612859
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving.
    Shiffman S, Shadel WG, Niaura R, Khayrallah MA, Jorenby DE, Ryan CF, Ferguson CL.
    Psychopharmacology (Berl); 2003 Apr; 166(4):343-50. PubMed ID: 12601502
    [Abstract] [Full Text] [Related]

  • 3. Comparative efficacy of rapid-release nicotine gum versus nicotine polacrilex gum in relieving smoking cue-provoked craving.
    Niaura R, Sayette M, Shiffman S, Glover ED, Nides M, Shelanski M, Shadel W, Koslo R, Robbins B, Sorrentino J.
    Addiction; 2005 Nov; 100(11):1720-30. PubMed ID: 16277632
    [Abstract] [Full Text] [Related]

  • 4. Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers.
    Tiffany ST, Cox LS, Elash CA.
    J Consult Clin Psychol; 2000 Apr; 68(2):233-40. PubMed ID: 10780123
    [Abstract] [Full Text] [Related]

  • 5. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
    Teneggi V, Tiffany ST, Squassante L, Milleri S, Ziviani L, Bye A.
    Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
    [Abstract] [Full Text] [Related]

  • 6. Effects of varenicline versus transdermal nicotine replacement therapy on cigarette demand on quit day in individuals with substance use disorders.
    Murphy CM, MacKillop J, Martin RA, Tidey JW, Colby SM, Rohsenow DJ.
    Psychopharmacology (Berl); 2017 Aug; 234(16):2443-2452. PubMed ID: 28500373
    [Abstract] [Full Text] [Related]

  • 7. Effect of nicotine lozenge use prior to smoking cue presentation on craving and withdrawal symptom severity.
    Kotlyar M, Vogel RI, Dufresne SR, Mills AM, Vuchetich JP.
    Drug Alcohol Depend; 2020 Jan 01; 206():107706. PubMed ID: 31757519
    [Abstract] [Full Text] [Related]

  • 8. Reactivity to nicotine cues over repeated cue reactivity sessions.
    LaRowe SD, Saladin ME, Carpenter MJ, Upadhyaya HP.
    Addict Behav; 2007 Dec 01; 32(12):2888-99. PubMed ID: 17537583
    [Abstract] [Full Text] [Related]

  • 9. A placebo-controlled randomized trial of D-cycloserine augmentation of cue exposure therapy for smoking cessation.
    Otto MW, Pachas GN, Cather C, Hoeppner SS, Moshier SJ, Hearon BA, Ward HB, Laffer AB, Smits JAJ, Evins AE.
    Cogn Behav Ther; 2019 Jan 01; 48(1):65-76. PubMed ID: 30111253
    [Abstract] [Full Text] [Related]

  • 10. The relevance and treatment of cue-induced cravings in tobacco dependence.
    Ferguson SG, Shiffman S.
    J Subst Abuse Treat; 2009 Apr 01; 36(3):235-43. PubMed ID: 18715743
    [Abstract] [Full Text] [Related]

  • 11. Effects of transdermal nicotine during imaginal exposure to anxiety and smoking cues in college smokers.
    Morissette SB, Palfai TP, Gulliver SB, Spiegel DA, Barlow DH.
    Psychol Addict Behav; 2005 Jun 01; 19(2):192-8. PubMed ID: 16011390
    [Abstract] [Full Text] [Related]

  • 12. Comparison of nicotine oral soluble film and nicotine lozenge on efficacy in relief of smoking cue-provoked acute craving after a single dose of treatment in low dependence smokers.
    Du D, Nides M, Borders J, Selmani A, Waverczak W.
    Psychopharmacology (Berl); 2014 Nov 01; 231(22):4383-91. PubMed ID: 24781517
    [Abstract] [Full Text] [Related]

  • 13. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S.
    Clin Ther; 2008 Aug 01; 30(8):1461-75. PubMed ID: 18803988
    [Abstract] [Full Text] [Related]

  • 14. Does acute tobacco smoking prevent cue-induced craving?
    Schlagintweit HE, Barrett SP.
    J Psychopharmacol; 2016 May 01; 30(5):468-73. PubMed ID: 27026532
    [Abstract] [Full Text] [Related]

  • 15. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
    Baker TB, Piper ME, Stein JH, Smith SS, Bolt DM, Fraser DL, Fiore MC.
    JAMA; 2016 Jan 26; 315(4):371-9. PubMed ID: 26813210
    [Abstract] [Full Text] [Related]

  • 16. Nicotine replacement therapy for smoking cessation.
    Stead LF, Perera R, Bullen C, Mant D, Lancaster T.
    Cochrane Database Syst Rev; 2008 Jan 23; (1):CD000146. PubMed ID: 18253970
    [Abstract] [Full Text] [Related]

  • 17. Nicotine replacement therapy for smoking cessation.
    Silagy C, Mant D, Fowler G, Lancaster T.
    Cochrane Database Syst Rev; 2000 Jan 23; (2):CD000146. PubMed ID: 10796494
    [Abstract] [Full Text] [Related]

  • 18. The impact of anticipated and unanticipated smoking opportunities on cigarette smoking and nicotine lozenge responses.
    Schlagintweit HE, Greer H, Good KP, Barrett SP.
    Drug Alcohol Depend; 2015 Feb 01; 147():97-102. PubMed ID: 25561388
    [Abstract] [Full Text] [Related]

  • 19. Effect of high-dose nicotine patch on craving and negative affect leading up to lapse episodes.
    Ferguson SG, Shiffman S.
    Psychopharmacology (Berl); 2014 Jul 01; 231(13):2595-602. PubMed ID: 24408214
    [Abstract] [Full Text] [Related]

  • 20. Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving.
    Selby P, Andriash K, Zawertailo L, Persad D, Zack M, Busto UE.
    J Clin Psychopharmacol; 2013 Oct 01; 33(5):667-74. PubMed ID: 23963055
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.